[PDF][PDF] Demographic and clinical characteristics of patients presenting with angiotensin-converting enzyme inhibitors induced cough

F Jamshed, H Jaffry, H Hanif, V Kumar, U Naz… - Cureus, 2019 - cureus.com
heart failure, adverse events associated with ACE inhibitors remain a major challenge for
the physicians. The ACEi-induced coughassociated with cases of ACEi-induced dry cough. …

Angiotensin-converting enzyme inhibitors; their efficacy, adverse effects, and the genetic influence on cough they may cause

AF Sheikh, FS Memon, NU Sahar - Molecular Medicine …, 2022 - rootspress.org
… inhibitors (ACE-Is) are the foremost usually advised drug to treat heart problems and other …
Enalapril-induced cough is associated with non-severe heart failure.” International journal of …

Adverse drug reactions to guideline-recommended heart failure drugs in women: a systematic review of the literature

SH Bots, F Groepenhoff, ALM Eikendal… - JACC: Heart Failure, 2019 - jacc.org
heart failure, heart decompensation, cardiac decompensation for the HF domain; and the
terms drug-related … The difference was especially pronounced for cough, which was almost 2.5 …

[PDF][PDF] Molecular Medicine Communications."

AF Sheikh, FS Memon, NU Sahar - 2022 - scholar.archive.org
… inhibitors (ACE-Is) are the foremost usually advised drug to treat heart problems and other …
Enalapril-induced cough is associated with non-severe heart failure.” International journal of …

[HTML][HTML] A systematic review on sex differences in adverse drug reactions related to psychotropic, cardiovascular, and analgesic medications

Y Shan, L Cheung, Y Zhou, Y Huang… - Frontiers in …, 2023 - frontiersin.org
… No sex difference was identified by this study in nifedipine related cough (men 3% vs. …
in nifedipine associated cough or amlodipine associated headache, dizziness, or tiredness. …

[HTML][HTML] WAO-ARIA consensus on chronic cough–Part III: Management strategies in primary and cough-specialty care. Updates in COVID-19

PW Rouadi, SA Idriss, J Bousquet, TM Laidlaw… - World Allergy …, 2022 - Elsevier
… Taken together, a 4-week therapy with intranasal corticosteroids is warranted (low evidence
of efficacy) in AR patients with upper airway disease-related cough. Patients who improve …

[PDF][PDF] WAO-ARIA consensus on chronic cough–Part III: Management strategies in primary and cough-specialty care. Updates in COVID-19

MAY Al-Nesf, TMN CABHSn, SL Bahna, EAJ DrPHp… - World - hal.science
… In COPD, a coughassociated chronic obstructive airway disease, an empirical trial of
bronchodilator therapy is often justified but requires more efficacy data.Unlike LTRAs49 and …